Skip to main content
Clinical Trials/NL-OMON28621
NL-OMON28621
Not yet recruiting
Not Applicable

Safe shortening of antibiotic treatment duration for complicated Staphylococcus aureus bacteremia

Amsterdam UMC0 sites400 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Staphylococcus aureus bacteremia
Sponsor
Amsterdam UMC
Enrollment
400
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Amsterdam UMC

Eligibility Criteria

Inclusion Criteria

  • Adults with methicillin\-sensitive complicated SAB with satisfactory clinical response to initial treatment will be eligible for inclusion.

Exclusion Criteria

  • Patients with infected prosthetic material or pregnant/lactating will be excluded.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Phase 1
Study to determine optimal duration of antibiotic treatment for Staphylococcus aureus bacteremia
EUCTR2019-004921-25-NLAmsterdam UMC396
Recruiting
Phase 4
Safe shortening of antibiotic treatment duration for complicated Staphylococcus aureus bacteremiaS. aureus bacteremiaS. aureus bloodstream infection10004018
NL-OMON54379Vrije Universiteit Medisch Centrum396
Active, not recruiting
Not Applicable
Optimal duration of antibiotic treatment in patients with complicated parapneumonic pleural effusions or empyemaDuration of antibiotic treatment in complicated parapneumonic pleural effusion and empyema.Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]
EUCTR2014-003137-25-ESJosé Manuel Porcel Pérez Hospital Arnau de Vilanova de Lleida Servicio Medicina Interna
Terminated
Not Applicable
STudy of Antibiotic Treatment In Children with chronic cough (STATIC)
ISRCTN88611534Royal Stoke University Hospital80
Active, not recruiting
Phase 1
Short versus extended antibiotic treatment for fever during low white blood cell counts in hematology patients with fever of unknown origin.Febrile neutropeniaMedDRA version: 19.1Level: PTClassification code 10063581Term: Stem cell transplantSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 19.1Level: LLTClassification code 10002969Term: Aplastic anemiaSystem Organ Class: 10005329 - Blood and lymphatic system disordersMedDRA version: 19.1Level: LLTClassification code 10003999Term: BacteremiaSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 19.1Level: LLTClassification code 10007810Term: Catheter related infectionSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 19.1Level: LLTClassification code 10028566Term: MyelomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 19.1Level: LLTClassification code 10062957Term: Catheter bacteraemiaSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 19.1Level: PTClassification code 10025310Term: LymphomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 19.1Level: LLTClassification code 10024329Term: LeukemiaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 19.1Level: PTClassification code 10056520Term: Catheter site infectionSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 19.1Level: PTClassification code 10016288Term: Febrile neutropeniaSystem Organ Class: 10005329 - Blood and lymphatic system disordersTherapeutic area: Diseases [C] - Bacterial Infections and Mycoses [C01]
EUCTR2014-001546-25-NLVU University Medical Center240